<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-04-26" modified="2020-10-07" version="185">
<accession>P61073</accession>
<accession>B2R5N0</accession>
<accession>O60835</accession>
<accession>P30991</accession>
<accession>P56438</accession>
<accession>Q53S69</accession>
<accession>Q9BXA0</accession>
<accession>Q9UKN2</accession>
<name>CXCR4_HUMAN</name>
<protein>
<recommendedName>
<fullName>C-X-C chemokine receptor type 4</fullName>
<shortName>CXC-R4</shortName>
<shortName>CXCR-4</shortName>
</recommendedName>
<alternativeName>
<fullName>FB22</fullName>
</alternativeName>
<alternativeName>
<fullName>Fusin</fullName>
</alternativeName>
<alternativeName>
<fullName>HM89</fullName>
</alternativeName>
<alternativeName>
<fullName>LCR1</fullName>
</alternativeName>
<alternativeName>
<fullName>Leukocyte-derived seven transmembrane domain receptor</fullName>
<shortName evidence="51">LESTR</shortName>
</alternativeName>
<alternativeName>
<fullName>Lipopolysaccharide-associated protein 3</fullName>
<shortName>LAP-3</shortName>
<shortName>LPS-associated protein 3</shortName>
</alternativeName>
<alternativeName>
<fullName>NPYRL</fullName>
</alternativeName>
<alternativeName>
<fullName>Stromal cell-derived factor 1 receptor</fullName>
<shortName>SDF-1 receptor</shortName>
</alternativeName>
<cdAntigenName>CD184</cdAntigenName>
</protein>
<gene>
<name type="primary">CXCR4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="DNA Cell Biol." volume="12" first="465" last="471">
<title>Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation.</title>
<authorList>
<person name="Herzog H."/>
<person name="Hort Y.J."/>
<person name="Shine J."/>
<person name="Selbie L.A."/>
</authorList>
<dbReference type="PubMed" id="8329116"/>
<dbReference type="DOI" id="10.1089/dna.1993.12.465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PRELIMINARY FUNCTION</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Regul. Pept." volume="47" first="247" last="258">
<title>A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells.</title>
<authorList>
<person name="Jazin E.E."/>
<person name="Yoo H."/>
<person name="Blomqvist A.G."/>
<person name="Yee F."/>
<person name="Weng G."/>
<person name="Walker M.W."/>
<person name="Salon J."/>
<person name="Larhammar D."/>
<person name="Wahlestedt C.R."/>
</authorList>
<dbReference type="PubMed" id="8234909"/>
<dbReference type="DOI" id="10.1016/0167-0115(93)90392-l"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PRELIMINARY FUNCTION</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1993" name="Genomics" volume="16" first="707" last="712">
<title>Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen.</title>
<authorList>
<person name="Federsppiel B."/>
<person name="Melhado I.G."/>
<person name="Duncan A.M.V."/>
<person name="Delaney A.D."/>
<person name="Schappert K."/>
<person name="Clark-Lewis I."/>
<person name="Jirik F.R."/>
</authorList>
<dbReference type="PubMed" id="8325644"/>
<dbReference type="DOI" id="10.1006/geno.1993.1251"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Fetal spleen</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="232" last="237">
<title>Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes.</title>
<authorList>
<person name="Loetscher M."/>
<person name="Geiser T."/>
<person name="O'Reilly T."/>
<person name="Zwahlen R."/>
<person name="Baggiolini M."/>
<person name="Moser B."/>
</authorList>
<dbReference type="PubMed" id="8276799"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Monocyte</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="Int. Immunol." volume="5" first="1239" last="1249">
<title>Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors.</title>
<authorList>
<person name="Nomura H."/>
<person name="Nielsen B.W."/>
<person name="Matsushima K."/>
</authorList>
<dbReference type="PubMed" id="7505609"/>
<dbReference type="DOI" id="10.1093/intimm/5.10.1239"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1996" name="Science" volume="272" first="872" last="877">
<title>HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.</title>
<authorList>
<person name="Feng Y."/>
<person name="Broder C.C."/>
<person name="Kennedy P.E."/>
<person name="Berger E.A."/>
</authorList>
<dbReference type="PubMed" id="8629022"/>
<dbReference type="DOI" id="10.1126/science.272.5263.872"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>CHARACTERIZATION OF ITS HIV-1 CORECEPTOR FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="4754" last="4760">
<title>Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1.</title>
<authorList>
<person name="Wegner S.A."/>
<person name="Ehrenberg P.K."/>
<person name="Chang G."/>
<person name="Dayhoff D.E."/>
<person name="Sleeker A.L."/>
<person name="Michael N.L."/>
</authorList>
<dbReference type="PubMed" id="9468539"/>
<dbReference type="DOI" id="10.1074/jbc.273.8.4754"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Peripheral blood leukocyte</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="FEBS Lett." volume="426" first="271" last="278">
<title>Genomic organization and promoter characterization of human CXCR4 gene.</title>
<authorList>
<person name="Caruz A."/>
<person name="Samsom M."/>
<person name="Alonso J.M."/>
<person name="Alcami J."/>
<person name="Baleux F."/>
<person name="Virelizier J.-L."/>
<person name="Parmentier M."/>
<person name="Arenzana-Seisdedos F."/>
</authorList>
<dbReference type="PubMed" id="9599023"/>
<dbReference type="DOI" id="10.1016/s0014-5793(98)00359-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="AIDS Res. Hum. Retroviruses" volume="15" first="1201" last="1208">
<title>Partial resistance to infection by R5X4 primary HIV type 1 isolates in an exposed-uninfected individual homozygous for CCR5 32-base pair deletion.</title>
<authorList>
<person name="Xiao L."/>
<person name="Weiss S.H."/>
<person name="Qari S.H."/>
<person name="Rudolph D."/>
<person name="Zhao C."/>
<person name="Denny T.N."/>
<person name="Hodge T."/>
<person name="Lal R.B."/>
</authorList>
<dbReference type="PubMed" id="10480633"/>
<dbReference type="DOI" id="10.1089/088922299310296"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="J. Recept. Signal Transduct." volume="18" first="321" last="344">
<title>Genomic organization and expression of the CXCR4 gene in mouse and man: absence of a splice variant corresponding to mouse CXCR4-B in human tissues.</title>
<authorList>
<person name="Frodl R."/>
<person name="Gierschik P."/>
<person name="Moepps B."/>
</authorList>
<dbReference type="PubMed" id="9879064"/>
<dbReference type="DOI" id="10.3109/10799899809047750"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Peripheral blood lymphocyte</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="J. Immunol." volume="163" first="2368" last="2372">
<title>CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant.</title>
<authorList>
<person name="Gupta S.K."/>
<person name="Pillarisetti K."/>
</authorList>
<dbReference type="PubMed" id="10452968"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Neutrophil</tissue>
</source>
</reference>
<reference key="12">
<citation type="submission" date="2001-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Fan Z."/>
<person name="Li T."/>
<person name="Li J."/>
<person name="Luo B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Adrenal gland</tissue>
</source>
</reference>
<reference key="14">
<citation type="submission" date="2003-02" db="EMBL/GenBank/DDBJ databases">
<title>cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).</title>
<authorList>
<person name="Warren C.N."/>
<person name="Aronstam R.S."/>
<person name="Sharma S.V."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="15">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="16">
<citation type="submission" date="2004-08" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="18">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="1996" name="Nature" volume="382" first="829" last="833">
<title>The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.</title>
<authorList>
<person name="Bleul C.C."/>
<person name="Farzan M."/>
<person name="Choe H."/>
<person name="Parolin C."/>
<person name="Clark-Lewis I."/>
<person name="Sodroski J."/>
<person name="Springer T.A."/>
</authorList>
<dbReference type="PubMed" id="8752280"/>
<dbReference type="DOI" id="10.1038/382829a0"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1996" name="Nature" volume="382" first="833" last="835">
<title>The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.</title>
<authorList>
<person name="Oberlin E."/>
<person name="Amara A."/>
<person name="Bachelerie F."/>
<person name="Bessia C."/>
<person name="Virelizier J.-L."/>
<person name="Arenzana-Seisdedos F."/>
<person name="Schwartz O."/>
<person name="Heard J.-M."/>
<person name="Clark-Lewis I."/>
<person name="Legler D.F."/>
<person name="Loetscher M."/>
<person name="Baggiolini M."/>
<person name="Moser B."/>
</authorList>
<dbReference type="PubMed" id="8752281"/>
<dbReference type="DOI" id="10.1038/382833a0"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1996" name="Nature" volume="384" first="288" last="288">
<authorList>
<person name="Oberlin E."/>
<person name="Amara A."/>
<person name="Bachelerie F."/>
<person name="Bessia C."/>
<person name="Virelizier J.-L."/>
<person name="Arenzana-Seisdedos F."/>
<person name="Schwartz O."/>
<person name="Heard J.-M."/>
<person name="Clark-Lewis I."/>
<person name="Legler D.F."/>
<person name="Loetscher M."/>
<person name="Baggiolini M."/>
<person name="Moser B."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:8752281</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1996" name="Science" volume="274" first="602" last="605">
<title>Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines.</title>
<authorList>
<person name="Lapham C.K."/>
<person name="Ouyang J."/>
<person name="Chandrasekhar B."/>
<person name="Nguyen N.Y."/>
<person name="Dimitrov D.S."/>
<person name="Golding H."/>
</authorList>
<dbReference type="PubMed" id="8849450"/>
<dbReference type="DOI" id="10.1126/science.274.5287.602"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>CHARACTERIZATION AS HIV-1 CORECEPTOR</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1996" name="Cell" volume="87" first="745" last="756">
<title>CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.</title>
<authorList>
<person name="Endres M.J."/>
<person name="Clapham P.R."/>
<person name="Marsh M."/>
<person name="Ahuja M."/>
<person name="Turner J.D."/>
<person name="McKnight A."/>
<person name="Thomas J.F."/>
<person name="Stoebenau-Haggarty B."/>
<person name="Choe S."/>
<person name="Vance P.J."/>
<person name="Wells T.N.C."/>
<person name="Power C.A."/>
<person name="Sutterwala S.S."/>
<person name="Doms R.W."/>
<person name="Landau N.R."/>
<person name="Hoxie J.A."/>
</authorList>
<dbReference type="PubMed" id="8929542"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81393-8"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>CHARACTERIZATION AS HIV-2 PRIMARY RECEPTOR IN SOME ISOLATES</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1998" name="Nat. Med." volume="4" first="72" last="77">
<title>AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.</title>
<authorList>
<person name="Donzella G.A."/>
<person name="Schols D."/>
<person name="Lin S.W."/>
<person name="Este J.A."/>
<person name="Nagashima K.A."/>
<person name="Maddon P.J."/>
<person name="Allaway G.P."/>
<person name="Sakmar T.P."/>
<person name="Henson G."/>
<person name="De Clercq E."/>
<person name="Moore J.P."/>
</authorList>
<dbReference type="PubMed" id="9427609"/>
<dbReference type="DOI" id="10.1038/nm0198-072"/>
</citation>
<scope>ANTAGONIST</scope>
<scope>INTERACTION WITH CXCL12</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>CHARACTERIZATION AS HIV-1 CORECEPTOR</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1999" name="Cell" volume="96" first="667" last="676">
<title>Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.</title>
<authorList>
<person name="Farzan M."/>
<person name="Mirzabekov T."/>
<person name="Kolchinsky P."/>
<person name="Wyatt R."/>
<person name="Cayabyab M."/>
<person name="Gerard N.P."/>
<person name="Gerard C."/>
<person name="Sodroski J."/>
<person name="Choe H."/>
</authorList>
<dbReference type="PubMed" id="10089882"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80577-2"/>
</citation>
<scope>SULFATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1999" name="J. Virol." volume="73" first="2576" last="2586">
<title>Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses.</title>
<authorList>
<person name="Brelot A."/>
<person name="Heveker N."/>
<person name="Adema K."/>
<person name="Hosie M.J."/>
<person name="Willett B."/>
<person name="Alizon M."/>
</authorList>
<dbReference type="PubMed" id="10074102"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ARG-183; ARG-188 AND ASP-193</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1999" name="J. Virol." volume="73" first="2752" last="2761">
<title>Identification of CXCR4 domains that support coreceptor and chemokine receptor functions.</title>
<authorList>
<person name="Doranz B.J."/>
<person name="Orsini M.J."/>
<person name="Turner J.D."/>
<person name="Hoffman T.L."/>
<person name="Berson J.F."/>
<person name="Hoxie J.A."/>
<person name="Peiper S.C."/>
<person name="Brass L.F."/>
<person name="Doms R.W."/>
</authorList>
<dbReference type="PubMed" id="10074122"/>
</citation>
<scope>DOMAINS</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HIV-1 SURFACE PROTEIN GP120</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="2479" last="2485">
<title>beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4.</title>
<authorList>
<person name="Cheng Z.J."/>
<person name="Zhao J."/>
<person name="Sun Y."/>
<person name="Hu W."/>
<person name="Wu Y.L."/>
<person name="Cen B."/>
<person name="Wu G.-X."/>
<person name="Pei G."/>
</authorList>
<dbReference type="PubMed" id="10644702"/>
<dbReference type="DOI" id="10.1074/jbc.275.4.2479"/>
</citation>
<scope>INTERACTION WITH ARRB2</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="23736" last="23744">
<title>Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.</title>
<authorList>
<person name="Brelot A."/>
<person name="Heveker N."/>
<person name="Montes M."/>
<person name="Alizon M."/>
</authorList>
<dbReference type="PubMed" id="10825158"/>
<dbReference type="DOI" id="10.1074/jbc.m000776200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CXCL12</scope>
<scope>MUTAGENESIS OF 2-GLU--SER-9; 4-ILE--ASP-20; TYR-7; 10-ASP--ASP-20; TYR-12; 14-GLU-GLU-15; TYR-21; ASP-97; ASP-171; ASP-187; ASP-193; ASP-262; GLU-268 AND GLU-288</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2000" name="J. Virol." volume="74" first="4404" last="4413">
<title>N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.</title>
<authorList>
<person name="Chabot D.J."/>
<person name="Chen H."/>
<person name="Dimitrov D.S."/>
<person name="Broder C.C."/>
</authorList>
<dbReference type="PubMed" id="10756055"/>
<dbReference type="DOI" id="10.1128/jvi.74.9.4404-4413.2000"/>
</citation>
<scope>GLYCOSYLATION AT ASN-11</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HIV-1 ENV</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF ASN-11; THR-13 AND ASN-176</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="11466" last="11471">
<title>Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.</title>
<authorList>
<person name="Xiao H."/>
<person name="Neuveut C."/>
<person name="Tiffany H.L."/>
<person name="Benkirane M."/>
<person name="Rich E.A."/>
<person name="Murphy P.M."/>
<person name="Jeang K.-T."/>
</authorList>
<dbReference type="PubMed" id="11027346"/>
<dbReference type="DOI" id="10.1073/pnas.97.21.11466"/>
</citation>
<scope>INDUCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HIV-1 TAT</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2001" name="Nat. Immunol." volume="2" first="338" last="345">
<title>A CD14-independent LPS receptor cluster.</title>
<authorList>
<person name="Triantafilou K."/>
<person name="Triantafilou M."/>
<person name="Dedrick R.L."/>
</authorList>
<dbReference type="PubMed" id="11276205"/>
<dbReference type="DOI" id="10.1038/86342"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION AS LPS RECEPTOR</scope>
<scope>INTERACTION WITH GDF5; HSP90AA1 AND HSPA8</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="29484" last="29489">
<title>The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry.</title>
<authorList>
<person name="Farzan M."/>
<person name="Babcock G.J."/>
<person name="Vasilieva N."/>
<person name="Wright P.L."/>
<person name="Kiprilov E."/>
<person name="Mirzabekov T."/>
<person name="Choe H."/>
</authorList>
<dbReference type="PubMed" id="12034737"/>
<dbReference type="DOI" id="10.1074/jbc.m203361200"/>
</citation>
<scope>GLYCOSYLATION AT SER-18</scope>
<scope>IDENTIFICATION OF PROTEOGLYCAN</scope>
<scope>INTERACTION WITH CXCL12</scope>
<scope>SULFATION AT TYR-21</scope>
<scope>MUTAGENESIS OF TYR-7; THR-8; SER-9; TYR-12; SER-18 AND TYR-21</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2003" name="Dev. Cell" volume="5" first="709" last="722">
<title>The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4.</title>
<authorList>
<person name="Marchese A."/>
<person name="Raiborg C."/>
<person name="Santini F."/>
<person name="Keen J.H."/>
<person name="Stenmark H."/>
<person name="Benovic J.L."/>
</authorList>
<dbReference type="PubMed" id="14602072"/>
<dbReference type="DOI" id="10.1016/s1534-5807(03)00321-6"/>
</citation>
<scope>UBIQUITINATION BY ITCH</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2003" name="Nat. Genet." volume="34" first="70" last="74">
<title>Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.</title>
<authorList>
<person name="Hernandez P.A."/>
<person name="Gorlin R.J."/>
<person name="Lukens J.N."/>
<person name="Taniuchi S."/>
<person name="Bohinjec J."/>
<person name="Francois F."/>
<person name="Klotman M.E."/>
<person name="Diaz G.A."/>
</authorList>
<dbReference type="PubMed" id="12692554"/>
<dbReference type="DOI" id="10.1038/ng1149"/>
</citation>
<scope>INVOLVEMENT IN WHIMS</scope>
<scope>VARIANTS WHIMS 334-ARG--SER-352 DEL AND 343-GLU--SER-352 DEL</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2005" name="Blood" volume="105" first="2449" last="2457">
<title>WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.</title>
<authorList>
<person name="Balabanian K."/>
<person name="Lagane B."/>
<person name="Pablos J.L."/>
<person name="Laurent L."/>
<person name="Planchenault T."/>
<person name="Verola O."/>
<person name="Lebbe C."/>
<person name="Kerob D."/>
<person name="Dupuy A."/>
<person name="Hermine O."/>
<person name="Nicolas J.F."/>
<person name="Latger-Cannard V."/>
<person name="Bensoussan D."/>
<person name="Bordigoni P."/>
<person name="Baleux F."/>
<person name="Le Deist F."/>
<person name="Virelizier J.L."/>
<person name="Arenzana-Seisdedos F."/>
<person name="Bachelerie F."/>
</authorList>
<dbReference type="PubMed" id="15536153"/>
<dbReference type="DOI" id="10.1182/blood-2004-06-2289"/>
</citation>
<scope>INVOLVEMENT IN WHIMS</scope>
<scope>VARIANT WHIMS 338-SER--SER-352 DEL</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2007" name="Blood" volume="109" first="1825" last="1833">
<title>Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells.</title>
<authorList>
<person name="Forde S."/>
<person name="Tye B.J."/>
<person name="Newey S.E."/>
<person name="Roubelakis M."/>
<person name="Smythe J."/>
<person name="McGuckin C.P."/>
<person name="Pettengell R."/>
<person name="Watt S.M."/>
</authorList>
<dbReference type="PubMed" id="17077324"/>
<dbReference type="DOI" id="10.1182/blood-2006-05-023028"/>
</citation>
<scope>INTERACTION WITH CD164</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="5111" last="5115">
<title>Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation.</title>
<authorList>
<person name="Berchiche Y.A."/>
<person name="Chow K.Y."/>
<person name="Lagane B."/>
<person name="Leduc M."/>
<person name="Percherancier Y."/>
<person name="Fujii N."/>
<person name="Tamamura H."/>
<person name="Bachelerie F."/>
<person name="Heveker N."/>
</authorList>
<dbReference type="PubMed" id="17197449"/>
<dbReference type="DOI" id="10.1074/jbc.c600270200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASN-119; ASP-133; ARG-134 AND TYR-135</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="Biochemistry" volume="47" first="11251" last="11262">
<title>Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases.</title>
<authorList>
<person name="Seibert C."/>
<person name="Veldkamp C.T."/>
<person name="Peterson F.C."/>
<person name="Chait B.T."/>
<person name="Volkman B.F."/>
<person name="Sakmar T.P."/>
</authorList>
<dbReference type="PubMed" id="18834145"/>
<dbReference type="DOI" id="10.1021/bi800965m"/>
</citation>
<scope>SULFATION AT TYR-7; TYR-12 AND TYR-21</scope>
<scope>INTERACTION WITH CXCL12</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-319 AND SER-348</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2009" name="Mol. Biol. Cell" volume="20" first="1324" last="1339">
<title>The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction.</title>
<authorList>
<person name="Bhandari D."/>
<person name="Robia S.L."/>
<person name="Marchese A."/>
</authorList>
<dbReference type="PubMed" id="19116316"/>
<dbReference type="DOI" id="10.1091/mbc.e08-03-0308"/>
</citation>
<scope>INTERACTION WITH ITCH</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-324 AND SER-325</scope>
<scope>MUTAGENESIS OF SER-324; SER-325 AND SER-330</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2009" name="Neoplasia" volume="11" first="333" last="344">
<title>Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.</title>
<authorList>
<person name="Walenkamp A.M."/>
<person name="Boer I.G."/>
<person name="Bestebroer J."/>
<person name="Rozeveld D."/>
<person name="Timmer-Bosscha H."/>
<person name="Hemrika W."/>
<person name="van Strijp J.A."/>
<person name="de Haas C.J."/>
</authorList>
<dbReference type="PubMed" id="19308288"/>
<dbReference type="DOI" id="10.1593/neo.81508"/>
</citation>
<scope>INTERACTION WITH STAPHYLOCOCCUS AUREUS SUPERANTIGEN-LIKE PROTEIN 10 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="7805" last="7817">
<title>Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling.</title>
<authorList>
<person name="Busillo J.M."/>
<person name="Armando S."/>
<person name="Sengupta R."/>
<person name="Meucci O."/>
<person name="Bouvier M."/>
<person name="Benovic J.L."/>
</authorList>
<dbReference type="PubMed" id="20048153"/>
<dbReference type="DOI" id="10.1074/jbc.m109.091173"/>
</citation>
<scope>PHOSPHORYLATION AT SER-321; SER-324; SER-325; SER-330; SER-339 AND SER-351</scope>
<scope>INTERACTION WITH ARRB2 AND ARRC</scope>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="15566" last="15576">
<title>CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin.</title>
<authorList>
<person name="Saini V."/>
<person name="Marchese A."/>
<person name="Majetschak M."/>
</authorList>
<dbReference type="PubMed" id="20228059"/>
<dbReference type="DOI" id="10.1074/jbc.m110.103408"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH UBIQUITIN</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="1160" last="1170">
<title>F-actin-binding protein drebrin regulates CXCR4 recruitment to the immune synapse.</title>
<authorList>
<person name="Perez-Martinez M."/>
<person name="Gordon-Alonso M."/>
<person name="Cabrero J.R."/>
<person name="Barrero-Villar M."/>
<person name="Rey M."/>
<person name="Mittelbrunn M."/>
<person name="Lamana A."/>
<person name="Morlino G."/>
<person name="Calabia C."/>
<person name="Yamazaki H."/>
<person name="Shirao T."/>
<person name="Vazquez J."/>
<person name="Gonzalez-Amaro R."/>
<person name="Veiga E."/>
<person name="Sanchez-Madrid F."/>
</authorList>
<dbReference type="PubMed" id="20215400"/>
<dbReference type="DOI" id="10.1242/jcs.064238"/>
</citation>
<scope>INTERACTION WITH DBN1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="2529" last="2541">
<title>Arrestin-2 interacts with the endosomal sorting complex required for transport machinery to modulate endosomal sorting of CXCR4.</title>
<authorList>
<person name="Malik R."/>
<person name="Marchese A."/>
</authorList>
<dbReference type="PubMed" id="20505072"/>
<dbReference type="DOI" id="10.1091/mbc.e10-02-0169"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH UBIQUITIN</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="51">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="22441" last="22455">
<title>Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway.</title>
<authorList>
<person name="Cheng S.B."/>
<person name="Quinn J.A."/>
<person name="Graeber C.T."/>
<person name="Filardo E.J."/>
</authorList>
<dbReference type="PubMed" id="21540189"/>
<dbReference type="DOI" id="10.1074/jbc.m111.224071"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2012" name="Blood" volume="119" first="4908" last="4918">
<title>Human cytomegalovirus-encoded UL33 and UL78 heteromerize with host CCR5 and CXCR4 impairing their HIV coreceptor activity.</title>
<authorList>
<person name="Tadagaki K."/>
<person name="Tudor D."/>
<person name="Gbahou F."/>
<person name="Tschische P."/>
<person name="Waldhoer M."/>
<person name="Bomsel M."/>
<person name="Jockers R."/>
<person name="Kamal M."/>
</authorList>
<dbReference type="PubMed" id="22496149"/>
<dbReference type="DOI" id="10.1182/blood-2011-08-372516"/>
</citation>
<scope>INDUCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HHV-5 PROTEIN UL78</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-321; SER-324 AND SER-325</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="54">
<citation type="journal article" date="2014" name="Blood" volume="123" first="1637" last="1646">
<title>The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.</title>
<authorList>
<person name="Hunter Z.R."/>
<person name="Xu L."/>
<person name="Yang G."/>
<person name="Zhou Y."/>
<person name="Liu X."/>
<person name="Cao Y."/>
<person name="Manning R.J."/>
<person name="Tripsas C."/>
<person name="Patterson C.J."/>
<person name="Sheehy P."/>
<person name="Treon S.P."/>
</authorList>
<dbReference type="PubMed" id="24366360"/>
<dbReference type="DOI" id="10.1182/blood-2013-09-525808"/>
</citation>
<scope>INVOLVEMENT IN WALDENSTROEM MACROGLOBULINEMIA</scope>
<scope>VARIANT 338-SER--SER-352 DEL</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2014" name="Blood" volume="123" first="2791" last="2796">
<title>Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.</title>
<authorList>
<person name="Treon S.P."/>
<person name="Cao Y."/>
<person name="Xu L."/>
<person name="Yang G."/>
<person name="Liu X."/>
<person name="Hunter Z.R."/>
</authorList>
<dbReference type="PubMed" id="24553177"/>
<dbReference type="DOI" id="10.1182/blood-2014-01-550905"/>
</citation>
<scope>INVOLVEMENT IN WALDENSTROEM MACROGLOBULINEMIA</scope>
<scope>VARIANTS 333-LYS--SER-352 DEL; 334-ARG--SER-352 DEL AND 338-SER--SER-352 DEL</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2015" name="Leukemia" volume="29" first="169" last="176">
<title>The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia.</title>
<authorList>
<person name="Cao Y."/>
<person name="Hunter Z.R."/>
<person name="Liu X."/>
<person name="Xu L."/>
<person name="Yang G."/>
<person name="Chen J."/>
<person name="Patterson C.J."/>
<person name="Tsakmaklis N."/>
<person name="Kanan S."/>
<person name="Rodig S."/>
<person name="Castillo J.J."/>
<person name="Treon S.P."/>
</authorList>
<dbReference type="PubMed" id="24912431"/>
<dbReference type="DOI" id="10.1038/leu.2014.187"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT 338-SER--SER-352 DEL</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2017" name="Am. J. Physiol." volume="313" first="C584" last="C592">
<title>RING finger protein 113A regulates C-X-C chemokine receptor type 4 stability and signaling.</title>
<authorList>
<person name="Lear T."/>
<person name="Dunn S.R."/>
<person name="McKelvey A.C."/>
<person name="Mir A."/>
<person name="Evankovich J."/>
<person name="Chen B.B."/>
<person name="Liu Y."/>
</authorList>
<dbReference type="PubMed" id="28978524"/>
<dbReference type="DOI" id="10.1152/ajpcell.00193.2017"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF LYS-331</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2006" name="J. Mol. Biol." volume="359" first="1400" last="1409">
<title>Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).</title>
<authorList>
<person name="Veldkamp C.T."/>
<person name="Seibert C."/>
<person name="Peterson F.C."/>
<person name="Sakmar T.P."/>
<person name="Volkman B.F."/>
</authorList>
<dbReference type="PubMed" id="16725153"/>
<dbReference type="DOI" id="10.1016/j.jmb.2006.04.052"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-38</scope>
<scope>SULFATION AT TYR-21</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH CXCL12</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2008" name="Sci. Signal." volume="1" first="RA4" last="RA4">
<title>Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12.</title>
<authorList>
<person name="Veldkamp C.T."/>
<person name="Seibert C."/>
<person name="Peterson F.C."/>
<person name="De la Cruz N.B."/>
<person name="Haugner J.C. III"/>
<person name="Basnet H."/>
<person name="Sakmar T.P."/>
<person name="Volkman B.F."/>
</authorList>
<dbReference type="PubMed" id="18799424"/>
<dbReference type="DOI" id="10.1126/scisignal.1160755"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-38 OF SULFATED MUTANT ALA-28 IN COMPLEX WITH CXCL12</scope>
</reference>
<reference key="60" evidence="3 4 5 6 7">
<citation type="journal article" date="2010" name="Science" volume="330" first="1066" last="1071">
<title>Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.</title>
<authorList>
<person name="Wu B."/>
<person name="Chien E.Y."/>
<person name="Mol C.D."/>
<person name="Fenalti G."/>
<person name="Liu W."/>
<person name="Katritch V."/>
<person name="Abagyan R."/>
<person name="Brooun A."/>
<person name="Wells P."/>
<person name="Bi F.C."/>
<person name="Hamel D.J."/>
<person name="Kuhn P."/>
<person name="Handel T.M."/>
<person name="Cherezov V."/>
<person name="Stevens R.C."/>
</authorList>
<dbReference type="PubMed" id="20929726"/>
<dbReference type="DOI" id="10.1126/science.1194396"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 2-325 OF MUTANTS LEU-125 AND THR-240 IN COMPLEX WITH ANTAGONISTS CVX15 AND IT1T</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
<scope>HOMODIMERIZATION</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2015" name="Science" volume="347" first="1117" last="1122">
<title>Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine.</title>
<authorList>
<person name="Qin L."/>
<person name="Kufareva I."/>
<person name="Holden L.G."/>
<person name="Wang C."/>
<person name="Zheng Y."/>
<person name="Zhao C."/>
<person name="Fenalti G."/>
<person name="Wu H."/>
<person name="Han G.W."/>
<person name="Cherezov V."/>
<person name="Abagyan R."/>
<person name="Stevens R.C."/>
<person name="Handel T.M."/>
</authorList>
<dbReference type="PubMed" id="25612609"/>
<dbReference type="DOI" id="10.1126/science.1261064"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 2-319 IN COMPLEX WITH HHV-8 VIRUS ORF K4 PROTEIN</scope>
<scope>INTERACTION WITH HHV-8 VIRUS ORF K4 PROTEIN</scope>
</reference>
<comment type="function">
<text evidence="11 14 17 18 20 22 29 30 34 36 37 42 44 45 46">Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces a signal by increasing intracellular calcium ion levels and enhancing MAPK1/MAPK3 activation (PubMed:10452968, PubMed:28978524, PubMed:18799424, PubMed:24912431). Involved in the AKT signaling cascade (PubMed:24912431). Plays a role in regulation of cell migration, e.g. during wound healing (PubMed:28978524). Acts as a receptor for extracellular ubiquitin; leading to enhanced intracellular calcium ions and reduced cellular cAMP levels (PubMed:20228059). Binds bacterial lipopolysaccharide (LPS) et mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205). Involved in hematopoiesis and in cardiac ventricular septum formation. Also plays an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodeling processes in endothelial cells. Involved in cerebellar development. In the CNS, could mediate hippocampal-neuron survival (By similarity).</text>
</comment>
<comment type="function">
<text evidence="15 19 47 48 49">(Microbial infection) Acts as a coreceptor (CD4 being the primary receptor) for human immunodeficiency virus-1/HIV-1 X4 isolates and as a primary receptor for some HIV-2 isolates. Promotes Env-mediated fusion of the virus (PubMed:8849450, PubMed:8929542, PubMed:9427609, PubMed:10074122, PubMed:10756055).</text>
</comment>
<comment type="subunit">
<text evidence="18 20 22 23 27 28 30 31 32 34 35 36 37 38 44">Monomer. Can form homodimers (PubMed:20929726). Interacts with CD164 (PubMed:17077324). Interacts with ARRB2; the interaction is dependent on the C-terminal phosphorylation of CXCR4 and allows activation of MAPK1 and MAPK3. Interacts with ARRC; the interaction is dependent on the C-terminal phosphorylation of CXCR4 and modulates calcium mobilization (PubMed:20048153). Interacts with RNF113A; the interaction, enhanced by CXCL12, promotes CXCR4 ubiquitination and subsequent degradation (PubMed:28978524). Interacts (via the cytoplasmic C-terminal) with ITCH (via the WW domains I and II); the interaction, enhanced by CXCL12, promotes CXCR4 ubiquitination and leads to its degradation. Interacts with extracellular ubiquitin. Interacts with DBN1; this interaction is enhanced by antigenic stimulation. Following LPS binding, may form a complex with GDF5, HSP90AA1 and HSPA8.</text>
</comment>
<comment type="subunit">
<text evidence="15 19 21 43">(Microbial infection) Interacts with HIV-1 surface protein gp120 and Tat.</text>
</comment>
<comment type="subunit">
<text evidence="49">(Microbial infection) Interacts with HHV-8 protein ORF K4 (PubMed:25612609).</text>
</comment>
<comment type="subunit">
<text evidence="39">(Microbial infection) May interact with human cytomegalovirus/HHV-5 protein UL78.</text>
</comment>
<comment type="subunit">
<text evidence="33">(Microbial infection) Interacts with Staphylococcus aureus protein SSL10.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-1965291">
<id>P25106</id>
<label>ACKR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>18</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-489756">
<id>P35348</id>
<label>ADRA1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-490017">
<id>P35368</id>
<label>ADRA1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-489993">
<id>P25100</id>
<label>ADRA1D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-6656842">
<id>P37288</id>
<label>AVPR1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-489374">
<id>P51681</id>
<label>CCR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-2115896">
<id>Q04900</id>
<label>CD164</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-2622890">
<id>P04233</id>
<label>CD74</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-12836456">
<id>P49682</id>
<label>CXCR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-489411">
<id>P61073</id>
<label>CXCR4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-2835269">
<id>P32302</id>
<label>CXCR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-351394">
<id>Q16643</id>
<label>DBN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-350338">
<id>P35579</id>
<label>MYH9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-973722">
<id>O60603</id>
<label>TLR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489411">
<id>P61073</id>
</interactant>
<interactant intactId="EBI-8786792">
<id>Q07266-1</id>
<label>Dbn1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17 54">Cell membrane</location>
<topology evidence="38">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Cell junction</location>
</subcellularLocation>
<subcellularLocation>
<location>Early endosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Late endosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Lysosome</location>
</subcellularLocation>
<text>In unstimulated cells, diffuse pattern on plasma membrane. On agonist stimulation, colocalizes with ITCH at the plasma membrane where it becomes ubiquitinated. In the presence of antigen, distributes to the immunological synapse forming at the T-cell-APC contact area, where it localizes at the peripheral and distal supramolecular activation cluster (SMAC).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P61073-1</id>
<id>P30991-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P61073-2</id>
<id>P30991-2</id>
<name>2</name>
<name>CXCR4-LO</name>
<sequence type="described" ref="VSP_001890"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text evidence="22">Expressed in numerous tissues, such as peripheral blood leukocytes, spleen, thymus, spinal cord, heart, placenta, lung, liver, skeletal muscle, kidney, pancreas, cerebellum, cerebral cortex and medulla (in microglia as well as in astrocytes), brain microvascular, coronary artery and umbilical cord endothelial cells. Isoform 1 is predominant in all tissues tested.</text>
</comment>
<comment type="induction">
<text evidence="39">(Microbial infection) May be down-regulated by Human cytomegalovirus/HHV-5.</text>
</comment>
<comment type="induction">
<text evidence="21">(Microbial infection) May be down-regulated by HIV-1 tat.</text>
</comment>
<comment type="domain">
<text evidence="15">The amino-terminus is critical for ligand binding. Residues in all four extracellular regions contribute to HIV-1 coreceptor activity.</text>
</comment>
<comment type="PTM">
<text evidence="25 32 34">Phosphorylated on agonist stimulation. Rapidly phosphorylated on serine and threonine residues in the C-terminal. Phosphorylation at Ser-324 and Ser-325 leads to recruitment of ITCH, ubiquitination and protein degradation.</text>
</comment>
<comment type="PTM">
<text evidence="25 44">Ubiquitinated after ligand binding, leading to its degradation (PubMed:28978524). Ubiquitinated by ITCH at the cell membrane on agonist stimulation. The ubiquitin-dependent mechanism, endosomal sorting complex required for transport (ESCRT), then targets CXCR4 for lysosomal degradation. This process is dependent also on prior Ser-/Thr-phosphorylation in the C-terminal of CXCR4. Also binding of ARRB1 to STAM negatively regulates CXCR4 sorting to lysosomes though modulating ubiquitination of SFR5S.</text>
</comment>
<comment type="PTM">
<text evidence="16 23 27 31">Sulfation on Tyr-21 is required for efficient binding of CXCL12/SDF-1alpha and promotes its dimerization. Tyr-7 and Tyr-12 are sulfated in a sequential manner after Tyr-21 is almost fully sulfated, with the binding affinity for CXCL12/SDF-1alpha increasing with the number of sulfotyrosines present. Sulfotyrosines Tyr-7 and Tyr-12 occupy clefts on opposing CXCL12 subunits, thus bridging the CXCL12 dimer interface and promoting CXCL12 dimerization.</text>
</comment>
<comment type="PTM">
<text evidence="19 23">O- and N-glycosylated. Asn-11 is the principal site of N-glycosylation. There appears to be very little or no glycosylation on Asn-176. N-glycosylation masks coreceptor function in both X4 and R5 laboratory-adapted and primary HIV-1 strains through inhibiting interaction with their Env glycoproteins. The O-glycosylation chondroitin sulfate attachment does not affect interaction with CXCL12/SDF-1alpha nor its coreceptor activity.</text>
</comment>
<comment type="disease" evidence="24 26">
<disease id="DI-02419">
<name>WHIM syndrome</name>
<acronym>WHIMS</acronym>
<description>Immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis.</description>
<dbReference type="MIM" id="193670"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="40 41">CXCR4 mutations play a role in the pathogenesis of Waldenstroem macroglobulinemia (WM) and influence disease presentation and outcome, as well as response to therapy. WM is a B-cell lymphoma characterized by accumulation of malignant lymphoplasmacytic cells in the bone marrow, lymph nodes and spleen, and hypersecretion of monoclonal immunoglobulin M (IgM). Excess IgM production results in serum hyperviscosity, tissue infiltration, and autoimmune-related pathology.</text>
</comment>
<comment type="miscellaneous">
<text>Plerixafor (AMD3100), an antagonist of CXCR4 activity, blocks HIV-1 entry, interaction with CXCL12 and subsequent CXCR4 signaling.</text>
</comment>
<comment type="similarity">
<text evidence="13">Belongs to the G-protein coupled receptor 1 family.</text>
</comment>
<comment type="caution">
<text evidence="20 23 49 56 57">Was originally thought to be a receptor for neuropeptide Y type 3 (NPY3R) (NPY3-R) (PubMed:8329116 and PubMed:8234909). Later reports showed that it acts as a receptor for the C-X-C chemokine CXCL12/SDF-1 (PubMed:9427609, PubMed:10825158, PubMed:12034737).</text>
</comment>
<comment type="sequence caution" evidence="52">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="CAA12166" version="1"/>
</conflict>
<text>Intron retention.</text>
</comment>
<comment type="online information" name="CXCR4base">
<link uri="http://structure.bmc.lu.se/idbase/CXCR4base/"/>
<text>CXCR4 mutation db</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/CXC_chemokine_receptors"/>
<text>CXC chemokine receptors entry</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/CXCR4"/>
<text>CXCR4 entry</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/cxcr4/"/>
</comment>
<dbReference type="EMBL" id="L01639">
<property type="protein sequence ID" value="AAA16594.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M99293">
<property type="protein sequence ID" value="AAA16617.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X71635">
<property type="protein sequence ID" value="CAA50641.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L06797">
<property type="protein sequence ID" value="AAA03209.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D10924">
<property type="protein sequence ID" value="BAA01722.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF005058">
<property type="protein sequence ID" value="AAB93982.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF052572">
<property type="protein sequence ID" value="AAC34581.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ224869">
<property type="protein sequence ID" value="CAA12166.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF025375">
<property type="protein sequence ID" value="AAB81970.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y14739">
<property type="protein sequence ID" value="CAA75034.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF147204">
<property type="protein sequence ID" value="AAF00130.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF348491">
<property type="protein sequence ID" value="AAK29630.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312244">
<property type="protein sequence ID" value="BAG35177.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY242129">
<property type="protein sequence ID" value="AAO92296.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT006660">
<property type="protein sequence ID" value="AAP35306.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY728138">
<property type="protein sequence ID" value="AAU05775.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC068492">
<property type="protein sequence ID" value="AAY24044.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471058">
<property type="protein sequence ID" value="EAX11616.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC020968">
<property type="protein sequence ID" value="AAH20968.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33295.1">
<molecule id="P61073-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46420.1"/>
<dbReference type="PIR" id="A45747">
<property type="entry name" value="A45747"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001008540.1">
<molecule id="P61073-2"/>
<property type="nucleotide sequence ID" value="NM_001008540.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334985.1">
<property type="nucleotide sequence ID" value="NM_001348056.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334988.1">
<property type="nucleotide sequence ID" value="NM_001348059.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334989.1">
<property type="nucleotide sequence ID" value="NM_001348060.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003458.1">
<molecule id="P61073-1"/>
<property type="nucleotide sequence ID" value="NM_003467.2"/>
</dbReference>
<dbReference type="PDB" id="2K03">
<property type="method" value="NMR"/>
<property type="chains" value="B/D=1-38"/>
</dbReference>
<dbReference type="PDB" id="2K04">
<property type="method" value="NMR"/>
<property type="chains" value="B/D=1-38"/>
</dbReference>
<dbReference type="PDB" id="2K05">
<property type="method" value="NMR"/>
<property type="chains" value="B/D=1-38"/>
</dbReference>
<dbReference type="PDB" id="2N55">
<property type="method" value="NMR"/>
<property type="chains" value="B=1-38"/>
</dbReference>
<dbReference type="PDB" id="3ODU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=2-319"/>
</dbReference>
<dbReference type="PDB" id="3OE0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=2-319"/>
</dbReference>
<dbReference type="PDB" id="3OE6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=2-325"/>
</dbReference>
<dbReference type="PDB" id="3OE8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/C=2-319"/>
</dbReference>
<dbReference type="PDB" id="3OE9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=2-319"/>
</dbReference>
<dbReference type="PDB" id="4RWS">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=2-228, A=231-319"/>
</dbReference>
<dbReference type="PDBsum" id="2K03"/>
<dbReference type="PDBsum" id="2K04"/>
<dbReference type="PDBsum" id="2K05"/>
<dbReference type="PDBsum" id="2N55"/>
<dbReference type="PDBsum" id="3ODU"/>
<dbReference type="PDBsum" id="3OE0"/>
<dbReference type="PDBsum" id="3OE6"/>
<dbReference type="PDBsum" id="3OE8"/>
<dbReference type="PDBsum" id="3OE9"/>
<dbReference type="PDBsum" id="4RWS"/>
<dbReference type="BMRB" id="P61073"/>
<dbReference type="SMR" id="P61073"/>
<dbReference type="BioGRID" id="113607">
<property type="interactions" value="55"/>
</dbReference>
<dbReference type="CORUM" id="P61073"/>
<dbReference type="DIP" id="DIP-34773N"/>
<dbReference type="DIP" id="DIP-46290N"/>
<dbReference type="IntAct" id="P61073">
<property type="interactions" value="40"/>
</dbReference>
<dbReference type="MINT" id="P61073"/>
<dbReference type="STRING" id="9606.ENSP00000386884"/>
<dbReference type="BindingDB" id="P61073"/>
<dbReference type="ChEMBL" id="CHEMBL2107"/>
<dbReference type="DrugBank" id="DB05501">
<property type="generic name" value="AMD-070"/>
</dbReference>
<dbReference type="DrugBank" id="DB00452">
<property type="generic name" value="Framycetin"/>
</dbReference>
<dbReference type="DrugBank" id="DB12698">
<property type="generic name" value="Ibalizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB12498">
<property type="generic name" value="Mogamulizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB06809">
<property type="generic name" value="Plerixafor"/>
</dbReference>
<dbReference type="DrugCentral" id="P61073"/>
<dbReference type="GuidetoPHARMACOLOGY" id="71"/>
<dbReference type="TCDB" id="9.A.14.13.17">
<property type="family name" value="the g-protein-coupled receptor (gpcr) family"/>
</dbReference>
<dbReference type="GlyGen" id="P61073">
<property type="glycosylation" value="3 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P61073"/>
<dbReference type="PhosphoSitePlus" id="P61073"/>
<dbReference type="SwissPalm" id="P61073"/>
<dbReference type="BioMuta" id="CXCR4"/>
<dbReference type="DMDM" id="46577576"/>
<dbReference type="jPOST" id="P61073"/>
<dbReference type="MassIVE" id="P61073"/>
<dbReference type="MaxQB" id="P61073"/>
<dbReference type="PaxDb" id="P61073"/>
<dbReference type="PeptideAtlas" id="P61073"/>
<dbReference type="PRIDE" id="P61073"/>
<dbReference type="ProteomicsDB" id="57256"/>
<dbReference type="ProteomicsDB" id="57257">
<molecule id="P61073-2"/>
</dbReference>
<dbReference type="ABCD" id="P61073">
<property type="antibodies" value="36 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="4421">
<property type="antibodies" value="1729 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7852"/>
<dbReference type="Ensembl" id="ENST00000241393">
<molecule id="P61073-1"/>
<property type="protein sequence ID" value="ENSP00000241393"/>
<property type="gene ID" value="ENSG00000121966"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000409817">
<molecule id="P61073-2"/>
<property type="protein sequence ID" value="ENSP00000386884"/>
<property type="gene ID" value="ENSG00000121966"/>
</dbReference>
<dbReference type="GeneID" id="7852"/>
<dbReference type="KEGG" id="hsa:7852"/>
<dbReference type="UCSC" id="uc002tuy.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7852"/>
<dbReference type="DisGeNET" id="7852"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000121966.6"/>
<dbReference type="GeneCards" id="CXCR4"/>
<dbReference type="HGNC" id="HGNC:2561">
<property type="gene designation" value="CXCR4"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000121966">
<property type="expression patterns" value="Tissue enhanced (bone marrow, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="CXCR4"/>
<dbReference type="MIM" id="162643">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="193670">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P61073"/>
<dbReference type="OpenTargets" id="ENSG00000121966"/>
<dbReference type="Orphanet" id="51636">
<property type="disease" value="WHIM syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27058"/>
<dbReference type="eggNOG" id="KOG3656">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214381"/>
<dbReference type="HOGENOM" id="CLU_009579_8_3_1"/>
<dbReference type="InParanoid" id="P61073"/>
<dbReference type="KO" id="K04189"/>
<dbReference type="OMA" id="IVHKWIS"/>
<dbReference type="OrthoDB" id="773026at2759"/>
<dbReference type="PhylomeDB" id="P61073"/>
<dbReference type="TreeFam" id="TF330966"/>
<dbReference type="PathwayCommons" id="P61073"/>
<dbReference type="Reactome" id="R-HSA-173107">
<property type="pathway name" value="Binding and entry of HIV virion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-376176">
<property type="pathway name" value="Signaling by ROBO receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380108">
<property type="pathway name" value="Chemokine receptors bind chemokines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418594">
<property type="pathway name" value="G alpha (i) signalling events"/>
</dbReference>
<dbReference type="SignaLink" id="P61073"/>
<dbReference type="SIGNOR" id="P61073"/>
<dbReference type="BioGRID-ORCS" id="7852">
<property type="hits" value="1 hit in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CXCR4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P61073"/>
<dbReference type="GeneWiki" id="CXCR4"/>
<dbReference type="GenomeRNAi" id="7852"/>
<dbReference type="Pharos" id="P61073">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P61073"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="P61073">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000121966">
<property type="expression patterns" value="Expressed in oviduct epithelium and 238 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P61073">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0031252">
<property type="term" value="C:cell leading edge"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005770">
<property type="term" value="C:late endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005764">
<property type="term" value="C:lysosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003779">
<property type="term" value="F:actin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019957">
<property type="term" value="F:C-C chemokine binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0016493">
<property type="term" value="F:C-C chemokine receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016494">
<property type="term" value="F:C-X-C chemokine receptor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038147">
<property type="term" value="F:C-X-C motif chemokine 12 receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019956">
<property type="term" value="F:chemokine binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0015026">
<property type="term" value="F:coreceptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008144">
<property type="term" value="F:drug binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004930">
<property type="term" value="F:G protein-coupled receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0032027">
<property type="term" value="F:myosin light chain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043130">
<property type="term" value="F:ubiquitin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019722">
<property type="term" value="P:calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0060048">
<property type="term" value="P:cardiac muscle contraction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060326">
<property type="term" value="P:cell chemotaxis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071345">
<property type="term" value="P:cellular response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006935">
<property type="term" value="P:chemotaxis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0038160">
<property type="term" value="P:CXCL12-activated CXCR4 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002407">
<property type="term" value="P:dendritic cell chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050966">
<property type="term" value="P:detection of mechanical stimulus involved in sensory perception of pain"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050965">
<property type="term" value="P:detection of temperature stimulus involved in sensory perception of pain"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045446">
<property type="term" value="P:endothelial cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061154">
<property type="term" value="P:endothelial tube morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002064">
<property type="term" value="P:epithelial cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019064">
<property type="term" value="P:fusion of virus membrane with host plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043217">
<property type="term" value="P:myelin maintenance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0022008">
<property type="term" value="P:neurogenesis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001764">
<property type="term" value="P:neuron migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008038">
<property type="term" value="P:neuron recognition"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050921">
<property type="term" value="P:positive regulation of chemotaxis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0120162">
<property type="term" value="P:positive regulation of cold-induced thermogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="YuBioLab"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1903861">
<property type="term" value="P:positive regulation of dendrite extension"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000448">
<property type="term" value="P:positive regulation of macrophage migration inhibitory factor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905322">
<property type="term" value="P:positive regulation of mesenchymal stem cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048714">
<property type="term" value="P:positive regulation of oligodendrocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035470">
<property type="term" value="P:positive regulation of vascular wound healing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051924">
<property type="term" value="P:regulation of calcium ion transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030155">
<property type="term" value="P:regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050920">
<property type="term" value="P:regulation of chemotaxis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043067">
<property type="term" value="P:regulation of programmed cell death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050792">
<property type="term" value="P:regulation of viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014823">
<property type="term" value="P:response to activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043278">
<property type="term" value="P:response to morphine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990478">
<property type="term" value="P:response to ultrasound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0022029">
<property type="term" value="P:telencephalon cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="DisProt" id="DP01249"/>
<dbReference type="InterPro" id="IPR022726">
<property type="entry name" value="Chemokine_CXCR4_N_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000355">
<property type="entry name" value="Chemokine_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001277">
<property type="entry name" value="CXCR4/ACKR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR000276">
<property type="entry name" value="GPCR_Rhodpsn"/>
</dbReference>
<dbReference type="InterPro" id="IPR017452">
<property type="entry name" value="GPCR_Rhodpsn_7TM"/>
</dbReference>
<dbReference type="Pfam" id="PF00001">
<property type="entry name" value="7tm_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12109">
<property type="entry name" value="CXCR4_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00657">
<property type="entry name" value="CCCHEMOKINER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00645">
<property type="entry name" value="CXCCHMKINER4"/>
</dbReference>
<dbReference type="PRINTS" id="PR00237">
<property type="entry name" value="GPCRRHODOPSN"/>
</dbReference>
<dbReference type="PROSITE" id="PS00237">
<property type="entry name" value="G_PROTEIN_RECEP_F1_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50262">
<property type="entry name" value="G_PROTEIN_RECEP_F1_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0297">G-protein coupled receptor</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0654">Proteoglycan</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0765">Sulfation</keyword>
<keyword id="KW-0807">Transducer</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="C-X-C chemokine receptor type 4" id="PRO_0000069352">
<location>
<begin position="1"/>
<end position="352"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="38">
<location>
<begin position="1"/>
<end position="38"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="38">
<location>
<begin position="39"/>
<end position="63"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="38">
<location>
<begin position="64"/>
<end position="77"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="38">
<location>
<begin position="78"/>
<end position="99"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="38">
<location>
<begin position="100"/>
<end position="110"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=3" evidence="38">
<location>
<begin position="111"/>
<end position="130"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="38">
<location>
<begin position="131"/>
<end position="154"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="38">
<location>
<begin position="155"/>
<end position="174"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="38">
<location>
<begin position="175"/>
<end position="195"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="38">
<location>
<begin position="196"/>
<end position="216"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="38">
<location>
<begin position="217"/>
<end position="241"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="38">
<location>
<begin position="242"/>
<end position="261"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="38">
<location>
<begin position="262"/>
<end position="282"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="38">
<location>
<begin position="283"/>
<end position="302"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="38">
<location>
<begin position="303"/>
<end position="352"/>
</location>
</feature>
<feature type="region of interest" description="Important for chemokine binding, signaling and HIV-1 coreceptor activity" evidence="20">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="region of interest" description="Chemokine binding" evidence="38 53">
<location>
<begin position="94"/>
<end position="97"/>
</location>
</feature>
<feature type="region of interest" description="Chemokine binding">
<location>
<begin position="113"/>
<end position="117"/>
</location>
</feature>
<feature type="region of interest" description="Involved in dimerization; when bound to chemokine">
<location>
<begin position="135"/>
<end position="147"/>
</location>
</feature>
<feature type="region of interest" description="Chemokine binding, important for signaling and HIV-1 coreceptor activity">
<location>
<begin position="186"/>
<end position="190"/>
</location>
</feature>
<feature type="region of interest" description="Involved in dimerization">
<location>
<begin position="191"/>
<end position="210"/>
</location>
</feature>
<feature type="region of interest" description="Involved in dimerization">
<location>
<begin position="266"/>
<end position="268"/>
</location>
</feature>
<feature type="short sequence motif" description="Important for signaling">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="binding site" description="Chemokine">
<location>
<position position="171"/>
</location>
</feature>
<feature type="binding site" description="Chemokine" evidence="38 53">
<location>
<position position="288"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine; partial" evidence="31">
<location>
<position position="7"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine; partial" evidence="31">
<location>
<position position="12"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="23 27 31">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="319"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 34">
<location>
<position position="321"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC and GRK6" evidence="10 32 34">
<location>
<position position="324"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC and GRK6" evidence="10 32 34">
<location>
<position position="325"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GRK6" evidence="34">
<location>
<position position="330"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GRK6" evidence="34">
<location>
<position position="339"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="348"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="34">
<location>
<position position="351"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
<location>
<position position="11"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Xyl...) (chondroitin sulfate) serine" evidence="23">
<location>
<position position="18"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="176"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 4 6 7 8 13 38">
<location>
<begin position="28"/>
<end position="274"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 4 5 6 7 8 13 38">
<location>
<begin position="109"/>
<end position="186"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="55">
<location>
<position position="331"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_001890" evidence="50">
<original>MEGIS</original>
<variation>MSIPLPLLQ</variation>
<location>
<begin position="1"/>
<end position="5"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with Waldenstroem macroglobulinemia; somatic mutation." id="VAR_081112" evidence="41">
<location>
<begin position="333"/>
<end position="352"/>
</location>
</feature>
<feature type="sequence variant" description="In WHIMS; also found in patients with Waldenstroem macroglobulinemia; somatic mutation." id="VAR_081113" evidence="24 41">
<location>
<begin position="334"/>
<end position="352"/>
</location>
</feature>
<feature type="sequence variant" description="In WHIMS; common somatic mutation in patients with Waldenstroem macroglobulinemia; results in decreased CXCL12-triggered receptor internalization; enhanced AKT and MAPK signaling activation; confers resistance to ibrutinib-triggered apoptosis." id="VAR_081114" evidence="26 40 41 42">
<location>
<begin position="338"/>
<end position="352"/>
</location>
</feature>
<feature type="sequence variant" description="In WHIMS." id="VAR_081115" evidence="24">
<location>
<begin position="343"/>
<end position="352"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced CXCL12 binding. Abolishes signaling." evidence="20">
<location>
<begin position="2"/>
<end position="9"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced CXCL12 binding. Impaired signaling. Reduced coreceptor activity for HIV-1 isolates LAI and NDK." evidence="20">
<location>
<begin position="4"/>
<end position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced coreceptor activity for HIV-1 isolates LAI and NDK. Greatly reduced coreceptor activity for HIV-1 isolates LAI and NDK; when associated with A-12." evidence="20 23">
<original>Y</original>
<variation>A</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="mutagenesis site" description="Sulfate incorporation greatly reduced; when associated with F-12 and F-21. Moderate reduction in sulfate incorporation; when associated with F-12 and A-18. No sulfate incorporation and binding SDF-1alpha greatly reduced; when associated with F-12; A-18 and F-21." evidence="20 23">
<original>Y</original>
<variation>F</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sulfate incorporation; when associated with A-9 and A-13." evidence="23">
<original>T</original>
<variation>A</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sulfate incorporation; when associated with A-8 and A-13." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="9"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced CXCL12 binding. No effect on signaling." evidence="20">
<location>
<begin position="10"/>
<end position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced molecular weight. Enhanced coreceptor activity on R5 HIV-1 isolate Envs. Slight further enhancement of coreceptor activity; when associated with A-13." evidence="19">
<original>N</original>
<variation>A</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced coreceptor activity for HIV-1 isolates LAI and NDK; when associated with A-7." evidence="20 23">
<original>Y</original>
<variation>A</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="mutagenesis site" description="Sulfate incorporation greatly reduced; when associated with F-7 and F-21. Moderate reduction in sulfate incorporation; when associated with F-7 and A-18. No sulfate incorporation and binding SDF-1alpha greatly reduced; when associated with F-7; A-18 and F-21." evidence="20 23">
<original>Y</original>
<variation>F</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced coreceptor activity on R5 HIV-1 isolate Envs. No effect on sulfate incorporation; when associated with A-8 and A-9." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="13"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced CXCL12 binding. Reduced coreceptor activity for HIV-1 isolate NDK." evidence="20">
<original>EE</original>
<variation>AA</variation>
<location>
<begin position="14"/>
<end position="15"/>
</location>
</feature>
<feature type="mutagenesis site" description="Sulfate incorporation greatly reduced; when associated with F-21. Moderate reduction in sulfate incorporation; when associated with F-7 and F-12. No sulfate incorporation and binding SDF-1alpha greatly reduced; when associated with F-7; F-12; and F-21." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced CXCL12 binding. Reduced coreceptor activity for HIV-1 isolates LAI and NDk." evidence="20 23">
<original>Y</original>
<variation>A</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Sulfate incorporation greatly reduced; when associated with F-7 and F-12. Sulfate incorporation greatly reduced; when associated with A-18. No sulfate incorporation and binding SDF-1alpha greatly reduced; when associated with F-7; F-12 and A-18." evidence="20 23">
<original>Y</original>
<variation>F</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced CXCL12 binding. Abolishes signaling. Markedly reduced coreceptor activity for HIV-1 isolate LAI." evidence="20">
<original>D</original>
<variation>N</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="mutagenesis site" description="No reduction of agonist-induced G-protein activation." evidence="29">
<original>N</original>
<variation>D</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of agonist-induced G-protein activation." evidence="29">
<original>N</original>
<variation>K</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive G-protein activation, with further activation induced by agonist." evidence="29">
<original>N</original>
<variation>S</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased thermostability.">
<original>L</original>
<variation>W</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="mutagenesis site" description="No reduction of agonist-induced G-protein activation." evidence="29">
<original>D</original>
<variation>N</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of agonist-induced G-protein activation." evidence="29">
<original>R</original>
<variation>A</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="mutagenesis site" description="No reduction of agonist-induced G-protein activation." evidence="29">
<original>Y</original>
<variation>A</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced coreceptor activity for HIV-1 isolate NDK." evidence="20">
<original>D</original>
<variation>N</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced coreceptor activity on R5 HIV-1 isolate Envs; when associated with A-11." evidence="19">
<original>N</original>
<variation>A</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced coreceptor activity for several HIV-1 isolates." evidence="14">
<original>R</original>
<variation>A</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced CXCL12 binding. Abolishes signaling." evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced coreceptor activity for several HIV-1 isolates." evidence="14">
<original>R</original>
<variation>A</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced coreceptor activity for HIV-1 isolate NDK. Reduced coreceptor activity for several other HIV-1 isolates." evidence="14 20">
<original>D</original>
<variation>A</variation>
<variation>S</variation>
<variation>N</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes coreceptor activity for HIV-1 isolate NDK. Reduced coreceptor activity for several other HIV-1 isolates." evidence="14 20">
<original>D</original>
<variation>R</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Retains ligand-binding affinity but abolishes signaling.">
<original>T</original>
<variation>P</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="mutagenesis site" description="Markedly reduced coreceptor activity for HIV-1 isolate LAI." evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="mutagenesis site" description="Markedly reduced coreceptor activity for HIV-1 isolate NDK. Less effect for HIV-1 isolate LAI." evidence="20">
<original>E</original>
<variation>A</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced CXCL12 binding. Impaired signaling. Reduced coreceptor activity for HIV-1 isolate LAI. Enhanced coreceptor activity for HIV-1 isolate NDK." evidence="20">
<original>E</original>
<variation>Q</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ubiquitination by RNF113A." evidence="44">
<original>K</original>
<variation>R</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderate degradation. About 60% reduction in binding ITCH and no ubiquitination nor protein degradation; when associated with A-325." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced binding to ITCH. Enhanced binding to ITCH and greatly increased protein degradation; when associated with D-324." evidence="32">
<original>S</original>
<variation>D</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced binding to ITCH. Enhanced binding to ITCH and greatly increased protein degradation; when associated with D-325." evidence="32">
<original>S</original>
<variation>D</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderate degradation. About 60% reduction in binding ITCH and no ubiquitination nor protein degradation; when associated with A-324." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on binding to ITCH." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ubiquitination by RNF113A." evidence="44">
<original>K</original>
<variation>R</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; AAK29630." ref="12" evidence="52">
<original>VIL</original>
<variation>IIP</variation>
<location>
<begin position="242"/>
<end position="244"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; BAG35177." ref="13" evidence="52">
<original>N</original>
<variation>S</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="9"/>
<end position="11"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="21"/>
<end position="23"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="32"/>
<end position="35"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="37"/>
<end position="62"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="63"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="67"/>
<end position="69"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="72"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="91"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="105"/>
<end position="139"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="145"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="155"/>
<end position="159"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="161"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="169"/>
<end position="174"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="175"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="181"/>
<end position="188"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="193"/>
<end position="207"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="209"/>
<end position="225"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="226"/>
<end position="228"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="231"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="274"/>
<end position="291"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="294"/>
<end position="301"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="302"/>
<end position="306"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="313"/>
<end position="317"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2K03"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2K05"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ODU"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OE0"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OE6"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OE8"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OE9"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RWS"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P70658"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00521"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10074102"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10074122"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10089882"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10452968"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10644702"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10756055"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10825158"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11027346"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11276205"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12034737"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12692554"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14602072"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15536153"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16725153"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17077324"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17197449"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18799424"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18834145"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19116316"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19308288"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20048153"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20215400"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20228059"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20505072"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20929726"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22496149"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24366360"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24553177"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24912431"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25612609"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28978524"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8752280"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8752281"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8849450"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8929542"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9427609"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10452968"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8276799"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000305"/>
<evidence key="53" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10825158"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20929726"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="28978524"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8234909"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8329116"/>
</source>
</evidence>
<sequence length="352" mass="39746" checksum="8C8476A186786B83" modified="2004-04-26" version="1">MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

